Express Scripts' US health cost initiative

27 April 2008

US pharmacy benefit management firm Express Scripts has announced a major initiative to advance consumer communications in health care, inspired by $600.0 million in savings, a six-fold increase for generics in a single drug category and new research results.

"We know that innovative communications and an advanced understanding of the consumer were critical in helping us save plan sponsors and consumers over half a billion dollars in the anti-cholesterol category alone," said George Paz, the firm's chief executive. "That is why we've launched a center of excellence with the nation's leading experts to advance thinking on consumer motivation and support our unique effort in this area," he said.

Generic statin use up to 53%

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight